TRYP- We have submitted a provisional patent to improve the formulation, delivery, and dosing of psychedelics, potentially reducing time patients spend in a dissociative state, further supporting a more controlled psychedelic experience.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.